Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast - March 2020

The increasing requirement of streamlining and centralization of healthcare administration is a major factor responsible for the growing adoption of electronic health records (EHRs) in various healthcare settings such as clinics and hospitals.

The governments of several countries around the world are increasingly implementing policies and regulations for promoting the usage of electronic health records in medical facilities.

For example, the Health Information Technology for Economic and Clinical Health (HITECH) Act was enacted in the U.S. in 2009 for promoting the utilization of EHR machines in medical facilities all over the country.Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/electronic-medical-records-market/report-sampleThe main goal of the HITECH Act was to improve and modernize the healthcare system in the country.

The EHRs not only significantly reduce the costs of healthcare but they also help tremendously in maintaining the quality standards of medical services.

In addition to this, the usage of EHRs makes the evaluation of epidemiology studies smoother and more efficient.

As a result, many regulatory bodies are increasingly preferring the use of these devices for assessing the data collected from the epidemiology studies.Thus, with the mushrooming usage of EHRs in healthcare settings and by regulatory organizations for evaluating epidemiology studies, the global electronic health record (EHR) market will grow, in valuation, from $22.3 billion to $30.4 billion from 2017 to 2023.

Market OverviewThe Global Legionella Testing Market is expected to grow at a CAGR of 9.7% during the forecasting period (2020-2027).Legionella is a bacteria that causes a severe form of pneumonia called Legionnaires disease or flu-like illness.

For instance, according to the Centers for Disease Control and Prevention (CDC), the US witnessed 6238 cases of Legionnaires' disease in 2017.

For instance, according to an article published on August 2, 2018, Nalco Water, an Ecolab company, has introduced a molecular-based test for Legionella that provides results 14-times faster than current culture testing methods to help to build and cooling tower operators manage public health risks from the waterborne pathogen.

The new Quantitative Polymerase Chain Reaction (qPCR) test is a part of the water safety analytical services platform.The surging awareness about legionellosis is also expected to drive the market.

Typical costs range from £200.00 for a small dental or GP practice to £500.00 for a medium-sized care home.The presence of strict government laws is also hindering the market.

Since the L8 Approved Code of Practice (3rd edition) (ACOP) was published, there has been a requirement for landlords of both business premises and domestic premises to evaluate the risks from exposure to Legionella to their tenants.

 Market InsightsMarket Research Future predicted that the global Medication Management system Market is set to reach the highest CAGR of 13.4% through the forecast period, 2018-2023.Medication management focuses on improving medication use for the patient's condition.

Several other factors, such as the emergence of funds in the healthcare sector and the need to reduce healthcare costs, are some of the drivers of the market.However, the high costs of software implementation and service maintenance can hinder the market growth during the forecast period.Regional OutlookThe United States has dominated the global drug management market.

This growth can be ascribed to the rise in the elderly population and the presence of the main market players in the region.Europe ranked second in 2017 due to the presence of developed economies such as the United Kingdom, Germany, France, and other countries in the region, which is an engine for market growth.The Asia Pacific region is likely to see the fastest growth in 2017.

Administration software segment is further classified as Bar Code Drug Delivery Software (BCMA) and Electronic Drug Management Software (eMAR).

The automatic distributor's segment is further classified as centralized automated distribution systems and decentralized automated distribution systems (ADS).

The decentralized automated dispensing system (ADS) comprises automated decentralized unit dose metering systems, pharmacy-based decentralized automated dispensing systems, and service-based decentralized automated dispensing systems.The services market segment is subdivided into point-of-care verification services and drug side effects monitoring.The global market, on the basis of delivery mode, is divided into on-premise solutions, web-based solutions, and cloud-based solutions.The market is segmented into pharmacies, hospitals, healthcare facilities, research institutes, and others, based on end-user.

Thelansis provides Market Forecasting, sales based forecast, patient share uptake, the average cost of therapy, annual cost of therapy, Epidemiology research, drug utilization study, patient-based forecasting with the help of domain experts which give enables our reports to serve as a critical support for informed decisions to our clients worldwide including US, EU, Japan, China, Singapore, etc.

Global Chemotherapy Market: Information by Drug Class (Alkylating Agents, Mitotic Inhibitors, Antimetabolites, Topoisomerase Inhibitors and Antitumor Antibiotic), Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Lymphoma, Leukemia and Ovarian Cancer), Route of Drug Administration (Intravenous, Oral, Subcutaneous, Intra-Muscular, Intravesicular, Topical, Intraperitoneal and Intraventricular/Intrathecal) and End-User (Specialty Centers and Hospitals & Clinics) - Global Forecast till 2027Market HighlightsThe Global Chemotherapy Market is estimated to be valued at USD 56,491.59 Million by 2024 and is expected to register a CAGR of 11.50% during the forecast period.The alkylating agents segment dominated the global chemotherapy market, by drug class, and is projected to reach USD 20,360.32 Million by 2024 and projected to be the fastest-growing segment during the forecast period.Americas dominated the market, accounting for the largest share of the market in 2018, and the regional market is expected to register a CAGR of 10.88% during the review period.

The European market was the second largest in 2018.

The market is projected to reach USD 18,292.73 Million by the end of 2024, with Germany being the leading market.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5791Segment AnalysisThe Global Chemotherapy Market has been segmented on the basis of drug class, indication, route of administration, end user, and region.

On the basis of drug class, the market has been divided into alkylating agents, antimetabolites, mitotic inhibitors, antitumor antibiotic, and topoisomerase inhibitors.

The alkylating agents segment held the majority market share in 2018 and anticipated to be the fastest growing, followed by the mitotic inhibitors segment.On the basis of indication, the market has been divided into lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, leukemia, lymphoma, and ovarian cancer.

The lung cancer segment accounted for the larger market share in 2018.

Veterinary surgical instruments Market Information; by Types (Scalpel handles, Forceps, Dressing, Scissors, Needle holders, Retractors); by Applications (Orthopedic, Sterilization, Ophthalmic, Dental); by Animals (Canines, Felines, Large Animals) - Global Forecast to 2023Global Veterinary Surgical Instruments Market – SynopsisVeterinary Surgical Instruments market is growing pervasively owing to the increasing awareness towards animal healthcare.

And, the sensitivity is just not limited to their pets but, it has widened towards wild, reptiles and venomous animals too.Other factors contributing to the market growth include increased R expenditure to bring novelties in these instruments, and development of better and effective materials, etc.

Factors such as rising demand for animal products like meat, wool, and milk along with the well- organized milk and meat industry impact the market growth positively.

Improving economic conditions across the globe enable access to the quality life by increasing consumers’ buying power and cost-effective veterinary equipment foster the market growth.On the other hand, factors impeding the market growth include, lack of awareness and knowledge gap regarding animal health and rising cost of pet care, etc.

Also, shortage of skilled labor and strict regulatory policies are the major restraints for the market growth.However, technological advancement, increasing number of ambulatory services and government and public organizations initiatives like PETA working towards animal rights and liberation are playing an integral role, providing impetus to the market growth.Key PlayersThe Global Veterinary Surgical Instruments Market is led by some of the fervent key players including Jørgen KRUUSE A/S, Eickemeyer Veterinary Equipment Inc., Surgical Holdings, Whittemore Enterprises, Inc., Sklar Instruments, and Medtronics, B.Braun.

The structure of Veterinary Surgical Instruments devices is changing due to the acquisition of local manufactures with multinational companies.

Bone Wax Market Analysis By Application (Orthopedic Surgery, Neurosurgery, Oral Surgery, Thoracic Surgery), End-Users, Key Players and Regional Outlook Forecast To 2023

Global Bone Wax Market is anticipated to demonstrate a CAGR of 3.5% during the forecast period (2018-2023) Predicted By Market Research Future (MRFR).

The surging number of surgical procedures due to orthopedic diseases is favoring the market growth across the globe.

The rising epidemiology of osteoarthritis and osteoporosis is considered one major factor influencing the market growth.

Furthermore, the introduction of synthetic bone wax has contributed to the growth of the market.

Synthetic bone wax is generally made of water-soluble polymers which helps to reduce the complications.